Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT04215978

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) San Diego, California, United States
  • UPMC Hillman Cancer Center (Univ Of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Blacktown Cancer And Haematology Centre Blacktown, New South Wales, Australia
View all 30 locations
View Trial Details
Completed

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

NCT05199753

Conditions
Advanced Solid Tumor
Locations
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
  • ICON Cancer Centre South Brisbane, Queensland, Australia
  • Cabrini Health Limited Malvern, Victoria, Australia
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

NCT05578872

Conditions
Adult Disease, Advanced Solid Tumor, Cutaneous Melanoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Denver Denver, Colorado, United States
View all 25 locations
View Trial Details
Completed

To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors

NCT05014828

Conditions
Advanced Solid Tumor
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 13 locations
View Trial Details

Related conditions